» Articles » PMID: 34208374

Pioglitazone Ameliorates Lipopolysaccharide-Induced Behavioral Impairment, Brain Inflammation, White Matter Injury and Mitochondrial Dysfunction in Neonatal Rats

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Jul 2
PMID 34208374
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies have demonstrated that pioglitazone, a peroxisome proliferator-activated receptor gamma (PPARγ) agonist, inhibits ischemia-induced brain injury. The present study was conducted to examine whether pioglitazone can reduce impairment of behavioral deficits mediated by inflammatory-induced brain white matter injury in neonatal rats. Intraperitoneal (i.p.) injection of lipopolysaccharide (LPS, 2 mg/kg) was administered to Sprague-Dawley rat pups on postnatal day 5 (P5), and i.p. administration of pioglitazone (20 mg/kg) or vehicle was performed 5 min after LPS injection. Sensorimotor behavioral tests were performed 24 h after LPS exposure, and changes in biochemistry of the brain was examined after these tests. The results show that systemic LPS exposure resulted in impaired sensorimotor behavioral performance, reduction of oligodendrocytes and mitochondrial activity, and increases in lipid peroxidation and brain inflammation, as indicated by the increment of interleukin-1β (IL-1β) levels and number of activated microglia in the neonatal rat brain. Pioglitazone treatment significantly improved LPS-induced neurobehavioral and physiological disturbances including the loss of body weight, hypothermia, righting reflex, wire-hanging maneuver, negative geotaxis, and hind-limb suspension in neonatal rats. The neuroprotective effect of pioglitazone against the loss of oligodendrocytes and mitochondrial activity was associated with attenuation of LPS-induced increment of thiobarbituric acid reactive substances (TBARS) content, IL-1β levels and number of activated microglia in neonatal rats. Our results show that pioglitazone prevents neurobehavioral disturbances induced by systemic LPS exposure in neonatal rats, and its neuroprotective effects are associated with its impact on microglial activation, IL-1β induction, lipid peroxidation, oligodendrocyte production and mitochondrial activity.

Citing Articles

Mitochondrial Dynamics in Brain Cells During Normal and Pathological Aging.

Sukhorukov V, Baranich T, Egorova A, Akateva A, Okulova K, Ryabova M Int J Mol Sci. 2024; 25(23).

PMID: 39684566 PMC: 11641149. DOI: 10.3390/ijms252312855.


From BBB to PPP: Bioenergetic requirements and challenges for oligodendrocytes in health and disease.

Fernandes M, Pernin F, Antel J, Kennedy T J Neurochem. 2024; 169(1):e16219.

PMID: 39253904 PMC: 11657931. DOI: 10.1111/jnc.16219.


Role of Microglial Modulation in Therapies for Perinatal Brain Injuries Leading to Neurodevelopmental Disorders.

Fleiss B, Gressens P Adv Neurobiol. 2024; 37:591-606.

PMID: 39207715 DOI: 10.1007/978-3-031-55529-9_33.


Neonatal brain inflammation enhances methamphetamine-induced reinstated behavioral sensitization in adult rats analyzed with explainable machine learning.

Wang K, Ojeda N, Wang H, Chiang H, Tucci M, Lee J Neurochem Int. 2024; 176:105743.

PMID: 38641026 PMC: 11102812. DOI: 10.1016/j.neuint.2024.105743.


PPAR Gamma Receptor: A Novel Target to Improve Morbidity in Preterm Babies.

Victor S, Forbes B, Greenough A, Edwards A Pharmaceuticals (Basel). 2023; 16(11).

PMID: 38004396 PMC: 10675178. DOI: 10.3390/ph16111530.


References
1.
Enomoto N, Takei Y, Hirose M, Konno A, Shibuya T, Matsuyama S . Prevention of ethanol-induced liver injury in rats by an agonist of peroxisome proliferator-activated receptor-gamma, pioglitazone. J Pharmacol Exp Ther. 2003; 306(3):846-54. DOI: 10.1124/jpet.102.047217. View

2.
Corona J, Duchen M . PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease. Free Radic Biol Med. 2016; 100:153-163. PMC: 5145801. DOI: 10.1016/j.freeradbiomed.2016.06.023. View

3.
Hermans R, Hunter D, McGivern R, Cain C, Longo L . Behavioral sequelae in young rats of acute intermittent antenatal hypoxia. Neurotoxicol Teratol. 1992; 14(2):119-29. DOI: 10.1016/0892-0362(92)90060-n. View

4.
Dehoux M, van Beneden R, Fernandez-Celemin L, Lause P, Thissen J . Induction of MafBx and Murf ubiquitin ligase mRNAs in rat skeletal muscle after LPS injection. FEBS Lett. 2003; 544(1-3):214-7. DOI: 10.1016/s0014-5793(03)00505-2. View

5.
Fernandez-Celemin L, Pasko N, Blomart V, Thissen J . Inhibition of muscle insulin-like growth factor I expression by tumor necrosis factor-alpha. Am J Physiol Endocrinol Metab. 2002; 283(6):E1279-90. DOI: 10.1152/ajpendo.00054.2002. View